Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
| ▸ | LAP3 | P28838 | 2/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 4/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3775670 | 0.84 | FDPS (0.49) | FDPSPLA2G2ASMPD1 | |
| SCHEMBL3775733 | 0.82 | FDPS (0.51) | FDPSPLA2G2ASMPD1LAP3 | |
| SCHEMBL11437610 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL9319046 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL17889069 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL17889074 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL15939593 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL21879674 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL22367822 | 0.82 | FDPS (0.41) | FDPS | |
| SCHEMBL410755 | 0.82 | FDPS (0.41) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357822-B2 | Process for producing high-purity chlorophosphite | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2013-01-22 | — | — | US | disclosed |
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | PHOSPHO1, RPP30, PCBP1 | FDPS 3149/4885PLA2G2A 1654/4885SMPD1 3992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.